Par-Avanir, LG, Samsung, Motorola, Liz Claiborne: Intellectual Property - Bloomberg

Par Pharmaceutical Cos. and units of Actavis Group HF were sued in federal court in Delaware by Avanir Pharmaceuticals Inc. (AVNR) for patent infringement related to plans to market generic versions of a drug used to control emotional outbursts. Avanir contends its rivals are violating two patents for Nuedexta, a treatment for pseudobulbar affect, or uncontrolled laughing or crying in patients with neurological disorders, according to court papers filed Aug. 10 in Wilmington.